Research: the way forward
With a robust research program, Roswell Park pioneers more effective treatments and prevention measures, providing patients with more options to maximize their chance for a cure. An emphasis on translational research allows us to develop our discoveries in the laboratory into promising therapeutics for patients — moving from lab bench to bedside — as quickly as possible.
Some areas of current research include:
- Novel targeted therapies: Our researchers are looking at ways to block signals between cancer cells.
- Decreasing toxicity of current treatments: We are exploring ways to make existing treatment more tolerable, such as by evaluation of specific genetic changes that are associated with increased risk of side effects.
- Non-invasive methods to predict response: Patient response to treatment is evaluated using methods such as the CellSearch System, which measures circulating tumor cells and other tests to predict a patient’s response or resistance to therapy.
Any new treatment undergoes years, even decades, of study and clinical studies, which involve people, encompass the final phases of cancer treatment research. Participating in a clinical study may be an important treatment option for many patients, who may be among the first to benefit from a new drug or therapy. About 50 percent of our patients are eligible for a clinical study. Whether or not you choose to participate is entirely your choice.